CD8A and neoplasm: Because anti-tumour T cell priming often occurs in the tumour-draining lymph node, we analysed T cells in the tumour-draining lymph nodes by IFNγ ELISpot to determine whether the modest increase in CD8+ T cells corresponded to an increase in tumour-specific T cell priming (figure 4f) [34,48].